|
Shimadzu Corporation is a diversified technology group operating across five business segments: measuring instruments, medical equipment, industrial equipment, aviation equipment, and other services. In measuring instruments, the company develops and sells chromatography, mass spectrometry, optical, thermal, X-ray, and electron beam analysis systems, along with water quality monitoring, material testing, and high-speed video cameras. Its medical equipment segment includes angiography systems, X-ray TV systems, general radiography, PET systems, near-infrared cameras, and radiation therapy equipment. The industrial equipment division manufactures turbo molecular pumps, hydraulic gear pumps, control valves, industrial furnaces, helium leak detectors, and high-speed sputtering systems. For aviation, the group produces flight control systems, air management systems, cockpit display systems, and engine auxiliary units. The company also engages in real estate leasing, management, and construction flooring through its other services segment. Key subsidiaries include Shimadzu Science, Shimadzu Diagnostics, Shimadzu Medical Systems, Shimadzu Aero Tech, and Shimadzu Precision Instruments Inc. The group serves customers in research, healthcare, industrial manufacturing, and aerospace sectors across global markets, with specific subsidiaries operating in the United States, Germany, the United Kingdom, China, Korea, Singapore, Malaysia, the United Arab Emirates, and Uruguay. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Scientific & Technical Instruments | Homepage shimadzu.com |
| Sector Technology | IR page shimadzu.com | |
|
Tags
analytical instruments, medical imaging, mass spectrometry, chromatography, industrial pumps, aviation systems, non-destructive testing, radiation therapy, hydraulic systems, real estate services, Shimadzu Science, Shimadzu Diagnostics, Shimadzu Rika, Shimadzu System Solutions, Shimadzu A-Tech, Shimadzu Scientific Instruments Inc., Shimadzu USA Manufacturing Inc., Shimadzu Europe GmbH, Kleitos Analytical Limited, Shimadzu (Hong Kong) Limited, Shimadzu Enterprise Management (China) Co. Ltd., Shimadzu Instruments (Suzhou) Co. Ltd., Shimadzu Scientific Korea Corporation, Shimadzu (Asia Pacific) Private Limited, Shimadzu Manufacturing Asia SDN BHD, Shimadzu Middle East and Africa FZE, Shimadzu Latin America S.A., Shimadzu Access, Shimadzu Techno Research, Shimadzu Research Laboratory (Europe) Limited, Shimane Shimadzu, Shimadzu Precision Instruments Inc., Beijing Shimadzu Medical Devices Co. Ltd., Shimadzu Medical Systems, Shimadzu Sangi Systems, Shimadzu Precision Technology, Tianjin Shimadzu Hydraulic Co. Ltd., Shimadzu Aero Tech, Shimadzu General Service, Taihei Kogyo
|
Press page shimadzu.com/med/news |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 1.19T |
| Market cap (USD) | $ 7.435B |
| P/E | 17.82 |
| PEG | 3.47 |
| P/BV | 2.05 |
| P/S | 2.03 |
| P/OCF | 19.09 |
| P/FCF | 31.24 |
| Dividend yield | 1.7% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 11.4% |
| ROI | 9.5% |
| ROIC | 8.6% |
| Profit margin | 10.8% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 5.1% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 15 |
| Quality score | 22.2% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 560.728B | 539.047B | 511.895B | 482.24B | 428.175B | 393.499B | 385.443B | 391.213B | 376.53B | 342.479B | 342.236B | 314.702B | 307.532B | 264.048B |
| Net profit | 60.499B | 53.776B | 57.037B | 52.048B | 47.289B | 36.097B | 31.766B | 32.523B | 29.838B | 26.473B | 23.899B | 18.445B | 9.724B | 7.578B |
| Free cash flow | 39.737B | 36.9B | 14.625B | 31.465B | 53.236B | 50.489B | 23.641B | 8.67B | 29.243B | 18.595B | 21.015B | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 3.686K | 3.73K | 4.237K | 4.137K | 4.236K | 4.007K | 2.844K | 3.202K | 2.989K | 1.768K | 1.765K | 1.34K | 916.27 | 670.64 |
| Price performance 12m | -0.01 | -0.12 | 0.02 | -0.02 | 0.06 | 0.41 | -0.11 | 0.07 | 0.69 | 0 | 0.32 | 0.46 | 0.37 | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 113B | 119B | 126B | 120B | 118B | 243B | 262B | 289B | 297B | 311B |
| ↳ YoY growth | +7.1% | +5.5% | +6.1% | -5.1% | -1.7% | +106.5% | +7.7% | +10.2% | +2.8% | +4.8% |
| ↳ 5y CAGR | +2.3% | +16.6% | +17.1% | +18.0% | +19.9% | +21.4% | ||||
| Borrowings, current (JPY) | 2.96B | 3.14B | 17.3B | 2.08B | 1.46B | 1.5B | 1.4B | 1.55B | 1.37B | — |
| Borrowings, non-current (JPY) | 15.6B | 15.5B | 247M | 30M | 281M | 205M | 132M | 66M | 4M | — |
| Bonds payable (JPY) | 15B | 15B | 15B | — | — | — | — | — | — | — |
| Lease liabilities (JPY) | 2.77B | 3.05B | 3.49B | 5.52B | 8.51B | 9.88B | 9.74B | 10.3B | 10.4B | 10.5B |
| Cash and deposits (JPY) | 56.7B | 76.9B | 73.6B | 70.9B | 113B | 158B | 159B | 165B | 143B | 167B |
| Intangible assets (JPY) | 8.4B | 9.23B | 10.8B | 11.4B | 11.6B | 11.2B | 17B | 18B | 23.7B | 23.9B |
| Net debt (borrowings + leases - cash) (JPY) | -35.3B | -55.2B | -52.6B | -63.2B | -103B | -146B | -148B | -153B | -132B | — |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 29.6B | 41.2B | 29.5B | 39.5B | 63.8B | 63.4B | 48.3B | 30.1B | 52B | 54.7B |
| Purchases of property, plant and equipment (JPY) | -11B | -12B | -20.8B | -15.9B | -13.3B | -10.1B | -16.8B | -15.5B | -15.1B | -14.9B |
| Change in receivables (cash effect) (JPY) | -7.91B | -6.91B | -6.47B | 4.38B | -5.44B | -220M | -1.05B | -6.9B | -4.39B | -1.93B |
| Change in inventories (cash effect) (JPY) | -3.82B | -5.51B | -2.59B | -5.48B | 3.13B | -5.25B | -16.2B | -7.18B | -4.22B | -4.63B |
| Change in payables (cash effect) (JPY) | 5.18B | 10B | -600M | -5.81B | -92M | 2.26B | -4.23B | -19.2B | -4.3B | -9.57B |
| Dividends paid (cash effect) (JPY) | -5.6B | -6.19B | -7.66B | -8.84B | -8.84B | -11.5B | -14.7B | -16.5B | -18.3B | -19.4B |
| Interest paid (cash effect) (JPY) | -138M | -139M | -124M | -103M | -180M | -188M | -281M | -293M | -262M | -304M |
| Income taxes paid (cash effect) (JPY) | -9.18B | -8.81B | -14.8B | -9.31B | -10.1B | -16.7B | -21.8B | -23.5B | -18.8B | -18.4B |
| Operating cash flow before change in receivables (JPY) | 37.5B | 48.1B | 35.9B | 35.1B | 69.2B | 63.6B | 49.4B | 37B | 56.4B | 56.6B |
| Free cash flow (OCF - PPE - intangibles) (JPY) | 18.6B | 29.2B | 8.67B | 23.6B | 50.5B | 53.2B | 31.5B | 14.6B | 36.9B | 39.7B |
| Income detail | ||||||||||
| Research and development expense (JPY) | 9.3B | 9.68B | 10.1B | 10.6B | 10.2B | 10.3B | 11B | 12.3B | 18.2B | 23.4B |
| ↳ 5y CAGR | +1.5% | +2.0% | +2.7% | +3.9% | +11.4% | +18.2% | ||||
| Total comprehensive income (JPY) | 27.8B | 33.2B | 28.2B | 24.3B | 51B | 57.1B | 57B | 85.4B | 49.2B | 86.7B |
| Comprehensive income to owners (JPY) | 27.8B | 33.1B | 28.2B | 24.3B | 51B | 57.1B | 57B | 85.4B | 49.2B | 86.7B |
| Provision for credit losses (JPY) | 250M | 364M | 399M | 247M | 377M | 119M | 178M | 50M | 64M | 265M |
| Credit cost ratio (credit losses / average receivables) (%) | 0.2% | 0.3% | 0.3% | 0.2% | 0.3% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% |
| Reported | Jun 30, 2017 | Jun 28, 2018 | Jun 27, 2019 | Jun 26, 2020 | Jun 28, 2021 | Jun 29, 2022 | Jun 29, 2023 | Jun 27, 2024 | Jun 25, 2025 | Jun 23, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| Jul 29, 2022 | Acquired | Acquired Nissui Pharmaceutical Co., Ltd. (EDINET code E00971). Its filings from before the deal are on its own company page, not shown here. |
ETFs Holding Shimadzu Corporation
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DWMF | 0.39% | 5,200 | $ 131.692K | Jun 30, 2026 |
| NTSI | 0.08% | 15,800 | $ 400.14K | Jun 30, 2026 |
| DFAI | 0.03% | 190,000 | $ 5.459M | Nov 12, 2026 |
| DFIC | 0.03% | 158,300 | $ 4.548M | Nov 12, 2026 |
| DFSI | 0.03% | 11,800 | $ 339.019K | Nov 12, 2026 |
| DFAX | 0.01% | 48,800 | $ 1.402M | Nov 12, 2026 |
| AVDE | 0.01% | 90,000 | $ 2.487M | Nov 16, 2026 |
| AVSD | 0.01% | 700 | $ 19.342K | Nov 16, 2026 |
| DXIV | 0.00% | 200 | $ 5,746.09 | Nov 12, 2026 |





























